Replimune Group
REPL
61 hedge funds and large institutions have $316M invested in Replimune Group in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 2 closing their positions.
750% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 2
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
22% more capital invested
Capital invested by funds: $258M → $316M (+$57.8M)
20% more funds holding
Funds holding: 51 → 61 (+10)
3.05% more ownership
Funds ownership: 58.64% → 61.7% (+3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$8.06M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$7.97M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.34M |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$5.92M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$3.69M |
| 2 |
BlackRock
New York
|
-$1.95M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$1.08M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.05M |
| 5 |
Goldman Sachs
New York
|
-$865K |
REPL Hedge Fund Activity: Q4 2019 in Review
61 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2019, worth a combined $316M — up 22% from $258M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new REPL positions and 2 closed out — a net gain of 15 holders — while 29 added to existing stakes and 9 trimmed.
The largest buyer was BVF Inc, adding an estimated $8.06M. The largest seller was Foresite Capital Management III, cutting an estimated $3.69M.
- 61 institutional investors held Replimune Group (REPL) as of Q4 2019, up from 51 in Q3 2019.
- Funds reported $316M of Replimune Group stock for Q4 2019, up 22% quarter-over-quarter.
- 17 funds opened new Replimune Group positions in Q4 2019 and 2 closed out, a net change of +15 holders.
- The largest Replimune Group buyer in Q4 2019 was BVF Inc, an estimated $8.06M added.
- The largest Replimune Group seller in Q4 2019 was Foresite Capital Management III, an estimated $3.69M sold.
Based on aggregated 13F filings for Q4 2019.